XYNOMIC PHARMACEUTICALS HOLDINGS, INC.

Xynomic Pharmaceuticals Holdings, Inc. is a blank check company that completed its initial public offering in 2017, targeting acquisition opportunities in the pharmaceutical and life sciences sector. The company filed a quarterly report on Form 10-Q with the SEC on August 7, 2018, reflecting its active status as a special purpose acquisition company in search of a qualifying business combination. Focused on the healthcare and pharmaceutical industry, Xynomic pursued targets at a time of heightened SPAC activity in biotech and drug development. Sponsor details are on record with the SEC under CIK 0001697805. For the full filing history, sponsor profile, deal timeline, and comparable SPAC analytics on Xynomic Pharmaceuticals Holdings, sign up for complete data access at SpacDesk.